Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)

China flag China · Delayed Price · Currency is CNY
34.72
+0.23 (0.67%)
Last updated: Jul 17, 2025
21.95%
Market Cap4.39B
Revenue (ttm)410.37M
Net Income (ttm)-25.52M
Shares Out126.54M
EPS (ttm)-0.20
PE Ration/a
Forward PEn/a
Dividend0.25 (0.72%)
Ex-Dividend DateMay 23, 2024
Volume14,052,535
Average Volume8,125,060
Open34.88
Previous Close34.49
Day's Range34.27 - 35.24
52-Week Range23.20 - 41.50
Beta-0.79
RSI57.64
Earnings DateAug 27, 2025

About SHE:301089

Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China. The company offers nucleoside (acid) products, such as pyrimidine series, purine series, and nucleotide series; nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, azithromycin, cytosine, 5-fluorocytosine, cytidine, uridine; and other APIs and pharmaceutical intermediates covering antiviral, anti-tumor, and nervous system. Tuoxin Pharmaceutical Group Co... [Read more]

Sector Healthcare
Founded 2001
Employees 1,551
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301089
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.